Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging
|
March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
BMJ Open
|
July 3, 2023
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO)
Anouk Verveen, Sander C J Verfaillie, Denise Visser, et al.
Neurology
|
April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic
Colin Groot, Ismael L Calandri, Ilse Bader, et al.
JAMA
|
June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
Alexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Nature Neuroscience
|
July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Rik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging
|
March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Rik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
BMJ Open
|
July 3, 2023
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO)
Anouk Verveen, Sander C J Verfaillie, Denise Visser, et al.
Neurology
|
April 16, 2026
Characterizing Individuals Fulfilling Clinical Criteria for Limbic-Predominant Age-Related TDP-43 Encephalopathy in a Tertiary Memory Clinic
Colin Groot, Ismael L Calandri, Ilse Bader, et al.
JAMA
|
June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
Alexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.
Nature Neuroscience
|
July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex
Rik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Page
of 4